Literature DB >> 13651732

REFLEX muscular spasm.

.   

Abstract

Entities:  

Keywords:  ANESTHESIA, REGIONAL; MUSCLES/diseases; SPINAL CORD/wounds and injuries

Mesh:

Year:  1959        PMID: 13651732      PMCID: PMC1993523     

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  9 in total

1.  Synovial fluid changes in intra-articular therapy; effect of prednisolone trimethylacetate.

Authors:  W R MURDOCH; G WILL
Journal:  Br Med J       Date:  1959-05-16

2.  A preliminary clinical report on a nondestructive method for the relief of so-called mass-reflex spasm.

Authors:  D MUNRO; E L SPATZ
Journal:  N Engl J Med       Date:  1959-01-01       Impact factor: 91.245

3.  Charcot's arthropathy following intra-articular hydrocortisone.

Authors:  G N CHANDLER; D T JONES; V WRIGHT; S J HARTFALL
Journal:  Br Med J       Date:  1959-04-11

4.  Further studies in prediabetes.

Authors:  W P JACKSON; N WOOLF
Journal:  Lancet       Date:  1957-03-23       Impact factor: 79.321

5.  The investigation of symptomless glycosuria with the galactose and cortisone modified glucose tolerance tests.

Authors:  R B GOUDIE; W P STAMM; S DISCHE
Journal:  J Clin Pathol       Date:  1958-09       Impact factor: 3.411

6.  An approach to the prediction of diabetes mellitus by modification of the glucose tolerance test with cortisone.

Authors:  S S FAJANS; J W CONN
Journal:  Diabetes       Date:  1954 Jul-Aug       Impact factor: 9.461

7.  The observed embryology of human single-ovum twins and other multiple births.

Authors:  G W CORNER
Journal:  Am J Obstet Gynecol       Date:  1955-11       Impact factor: 8.661

8.  An Account of a Blastodermic Vesicle of the Sheep of the Seventh Day, with Twin Germinal Areas.

Authors:  R Assheton
Journal:  J Anat Physiol       Date:  1898-04

9.  Glucose tolerance; a comparison of four types of diagnostic tests in 103 control subjects and 26 patients with diabetes.

Authors:  J H MEYER; C R WOMACK
Journal:  Am J Med Sci       Date:  1950-02       Impact factor: 2.378

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.